Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
08/1989
08/16/1989EP0328132A2 Therapeutic agent for thrombocytopenia
08/16/1989EP0328000A2 Indolocarbazole derivatives, process for their preparation and medicines containing same
08/16/1989EP0327986A2 Medicaments containing lactams, substituted lactams and process for their preparation
08/16/1989EP0327612A1 Pharmaceutical therapeutic use of glutathione derivatives
08/16/1989CN1034722A Triazolo (4.3-a)(1,4) benzodiazepine and thiopheno (3,2-f) (1,2,4) triazolo (4,3-a) (1,4) diazepine
08/15/1989US4857636 Stabilized tetramers
08/15/1989US4857533 Method of treatment for autoimmune diseases
08/15/1989US4857508 Novel platelet-aggregation inhibitor peptide derivatives
08/15/1989CA1258464A1 1,3-dioxan-5-ylalkenoic acids
08/15/1989CA1258452A1 Organic synthesis process of oligosaccharides containing galactosamine- uronic acid motives, oligosaccharides thus obtained and their biological uses
08/15/1989CA1258432A1 Blood coagulant
08/09/1989EP0327503A1 Use of IGF I in the manufacture of a medicament for the treatment of renal diseases
08/09/1989EP0326595A1 Peptides and antibodies that inhibit platelet adhesion
08/08/1989US4855489 Protein kinase c inhibitors
08/08/1989US4855449 Prostacyclin (PGI2) analogues
08/02/1989EP0326120A2 Human IFN-beta2/IL-6, its purification and uses
08/02/1989EP0326103A1 Pharmaceutical composition for 4-aroylimidazol-2-ones
08/02/1989EP0326034A2 Combination for the treatment of nervous cells and fibers illnesses and disorders
08/02/1989EP0326014A1 Composition of anticoagulants
08/02/1989EP0326013A2 Novel proteins derived from human alpha2-plasmin inhibitor or proteins similar thereto
08/02/1989CN1034313A Process for preparation of aloe products
08/01/1989US4853406 Anticoagulants
08/01/1989US4853404 Phenoxyacetic acid derivatives composition and use
08/01/1989US4853393 Hypotensive agents, anticoagulants
07/1989
07/27/1989WO1989006539A1 Process for preparation of aloe products
07/26/1989EP0325187A1 4-alkyl-1, 4-dihydropyridines with PAF-antagonist activity
07/26/1989EP0324988A1 4-Chlor-3-sulfamoyl benzoic acid hydrazides, process for their preparation, medicines containing them and use of these compounds in the preparation of diuretic and salt reducing activity medicines
07/26/1989EP0324802A1 Method for the treatment of body tissues and the administration of drugs thereto
07/25/1989US4851560 Inositol triphosphates
07/25/1989US4851423 Pharmaceutically active compounds
07/25/1989US4851408 Use of 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazol[5,4-d]azepine for releasing growth hormone
07/25/1989US4851345 Absorption during fibrin chromatography, then non-absorption in lysine chromatography
07/25/1989US4851224 Drying the precipitated acetylated mannose-based polysaccharid e obtained by adding a solvent to acidified aloe juice from th e leaf
07/25/1989US4851219 Method for the treatment of chronic myelogenous leukemia
07/19/1989EP0324597A2 Fibrin selective two-chain plasminogen activator
07/19/1989EP0324521A2 Method of treating haematologic diseases and pharmaceutical compositions to be used therefor
07/19/1989EP0324184A2 2-Amino-1,2,3,4-tetrahydroisoquinoline derivatives, method for their preparation and their use as medicines
07/18/1989US4849434 Novel thiazolidin-4-one derivatives and acid addition salts therof
07/18/1989US4849416 Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
07/18/1989CA1257588A1 Pyridazinones, the preparation thereof and pharmaceutical compositions containing these compounds
07/13/1989WO1989006131A1 1-aralkyl-1,2-dihydropyrimidine-2-thiones
07/12/1989EP0323807A2 Certain 2-substituted adenosine derivatives
07/12/1989EP0323740A2 Linear analogs of atrial natriuretic peptides
07/11/1989US4847303 Tert-butylphenyl compounds useful as anti-inflammatory agents
07/11/1989US4847276 Treatment of thromobocytosis with 5-(4-chlorophenyl)-2,4-diemthyl-3H-1,2,4-triazole-3-thione
07/11/1989US4847272 Anticoagulants
07/11/1989US4847265 clopidogrel and salts such as clopidogrel hydrogen sulfate; anticoagulants
07/11/1989CA1257287A1 7-oxabicycloheptane substituted thio prostaglandin analogs
07/11/1989CA1257286A1 7-oxabicycloheptane substituted thio prostaglandin analogs
07/11/1989CA1257285A1 7-oxabicycloheptane substituted oxa prostaglandin analogs
07/11/1989CA1257284A1 7-oxabicycloheptane ethers
07/11/1989CA1257272A1 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
07/11/1989CA1257271A1 6-vinyl-furo-(3,4-c)-pyridine derivatives
07/11/1989CA1257270A1 4-chloro-furo-(3,4-c)-pyridine derivatives
07/11/1989CA1257269A1 Furo-(3,4-c)-pyridine derivatives preparation thereof and therapeutic compositions containing the same
07/11/1989CA1257211A1 Process for obtaining a fviii/vwf complex having therapeutic effects and product thus prepared
07/05/1989EP0323149A2 Vectors and compounds for expression of zymogen forms of human protein C
07/05/1989EP0323147A2 1-Aralkyl-1,2-dihydropyrimidine-2-thiones
07/05/1989EP0322692A1 Heterocyclically substituted alkyl sulfone amides, method for their preparation, and pharmaceutical preparations
07/05/1989EP0322425A1 Process for preparing oil composition
07/04/1989US4845094 Hypoglycemic, anticoagulant
07/04/1989US4845078 Method for treating hematopoietic diseases
07/04/1989US4845076 Antiinflammatory agent
07/04/1989CA1256889A1 7-oxabicycloheptane substituted ethers
07/04/1989CA1256867A1 1,2-benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives
06/1989
06/29/1989WO1989005654A1 Linear analogs of atrial natriuretic peptides
06/28/1989EP0322094A1 N-terminal fragments of human serum albumin
06/28/1989EP0322033A2 New 2,5-diaryl tetrahydrofurans and analogs thereof as paf antagonists
06/28/1989EP0321526A1 Cloning and expression of human tissue factor
06/27/1989US4843165 Reacting 5-methoxy-1-indanone with trimethylsilyl cyanide to form cyanohydrin
06/27/1989US4843091 Indolylpropionic acids, compositions of, and use thereof to inhibit thrombocyte aggregation
06/27/1989US4843075 Anxiolytic
06/27/1989EP0309456A4 Process for replicating bone marrow.
06/27/1989CA1256438A1 Platelet aggregation inhibitory agents and intermediates therefor
06/27/1989CA1256433A1 1,7-naphthyridine derivatives and medicinal preparations containing same
06/21/1989EP0321094A2 Treatment of factor VIII inhibitors
06/21/1989EP0320992A2 Triazolodiazepine derivatives
06/21/1989EP0320984A2 1,4-Dihydropyridine derivatives
06/21/1989EP0320967A2 ANF derivatives with novel bridging
06/21/1989EP0320507A1 Scaled-up production of liposome-encapsulated hemoglobin.
06/20/1989US4841076 Diuretics, hypotensive agents
06/20/1989US4841041 Pentasaccharides and tetrasaccharides having anti-thrombotic activity
06/20/1989US4840970 Aqueous solution containing lipid-soluble pharmaceutical substance
06/20/1989US4840958 Novel 3-hydroxypyrid-2-ones and 3-hydroxyprid-4-ones useful in treating patients having a toxic concentration of iron
06/20/1989CA1256111A1 Benzodiioxinopyrrole derivatives
06/20/1989CA1256107A1 Pyrimidine derivatives, preparation thereof and use thereof
06/20/1989CA1256029A1 Process for making a stable pharmaceutical preparation of prostaglandin e compounds, and/or 15r thereof
06/20/1989CA1256027A1 Fibrinophilic urokinase complex and method for production thereof
06/15/1989WO1989005346A1 Stimulation of stem cell growth by the bryostatins
06/15/1989WO1989005148A1 A method of inhibiting platelet dependent arterial thrombosis
06/14/1989EP0320362A1 Use of 3-hydroxy-2-(4-methoxyphenyl)-5(2-methylamino-ethyl)-2,3-dihydro-5H-1,5-benzothiazepin-4-one derivatives in the preparation of medicaments inhibiting the platelet aggregation factor
06/14/1989EP0320361A1 3-Hydroxy-2-(4-methoxyphenyl)-5(2-methylaminoethyl)-2,3-dihydro-5H-1,5-benzothiazepin-4-one derivatives, their preparation and their use in therapy
06/14/1989EP0320075A1 8,9-Annelated-beta-carbolines and 8,9-annelated-3,4-dihydro-beta-carbolines
06/14/1989EP0319664A1 Soluble, iron-containing polypeptide derivatives, their preparation and pharmaceutical uses
06/14/1989EP0319559A1 Novel heparin derivatives
06/13/1989US4839388 Prostacyclins and pharmaceuticals containing the same
06/13/1989US4839348 Hypotensive agents; anticoagulants, antiischemic agents
06/13/1989US4839172 Composition of accelerating recovery of function of hematopoietic organs
06/13/1989US4839170 Administering methylamine, hydroxylamine or the nontoxic hydrochlorides intramuscularly
06/13/1989US4839169 Blood clot removal and inhibition